DermTech is a pioneering molecular dermatology company revolutionizing the detection of skin cancer and other skin conditions. Their core offering involves a non-invasive 'Smart Sticker™' technology that collects skin cells from the surface of a suspicious mole or lesion. These samples are then analyzed at the genomic level to identify biomarkers associated with conditions like melanoma. This approach aims to reduce the need for invasive surgical biopsies, improve diagnostic accuracy, and provide clinicians with actionable information for better patient management. DermTech's flagship product, the Pigmented Lesion Assay (PLA), helps assess the risk of melanoma early, enabling timely intervention.
The headquarters serves as the central node for corporate administration, research and development (R&D), clinical operations, and commercial strategy. Their CLIA-certified and CAP-accredited laboratory is also located here, processing patient samples.
Located in a modern facility within a well-known life sciences corridor, offering advanced laboratory spaces and collaborative office environments designed to foster innovation.
The work culture at DermTech is likely driven by scientific rigor, innovation, and a strong patient-centric mission. Collaboration between scientific, clinical, and commercial teams is essential for their success.
Its location in La Jolla provides strategic access to a rich talent pool from nearby universities and research institutions, as well as a vibrant biotech ecosystem for partnerships and collaborations.
DermTech's commercial operations and product availability are primarily focused on the United States market. While they may engage in international research collaborations or explore future market expansion, their direct clinical services and sales infrastructure are currently concentrated within the U.S.
11099 N Torrey Pines Rd #100
La Jolla
CA
USA
Address: N/A
Focus on US market from a central hub.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, DermTech, LLC' leadership includes:
DermTech, LLC has been backed by several prominent investors over the years, including:
DermTech has experienced significant leadership changes over the past 12-18 months, including the appointment of a new CEO, Bret Christensen, and a new CFO, Kevin Sun, to steer the company's commercialization and growth strategies. Former CEO John Dobak transitioned out during this period.
Discover the tools DermTech, LLC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
DermTech most commonly uses the email format of the employee's first initial followed by their last name. For example, if an employee's name is Jane Doe, her email address would likely be jdoe@dermtech.com.
[first_initial][last]@dermtech.com
Format
bchristensen@dermtech.com
Example
85%
Success rate
GlobeNewswire • May 8, 2024
DermTech announced its financial results for Q1 2024, reporting assay revenue of $3.7 million. The company highlighted progress in its trust and transparency initiatives and continued efforts to drive adoption of its DermTech Melanoma Test....more
GlobeNewswire • April 26, 2024
DermTech announced that its special meeting of stockholders, scheduled for April 26, 2024, was convened and adjourned without any business being conducted. The adjournment allows for further solicitation of proxies for proposals, including an increase in authorized shares....more
Seeking Alpha • February 28, 2024
Summary of DermTech's Q4 2023 earnings call, discussing financial performance, commercial strategies, test volume growth, and outlook for 2024. Key topics included market access improvements and efforts to expand insurance coverage....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including DermTech, LLC, are just a search away.